Recalcitrant Dermatomyositis Treated With Anifrolumab
Dermatomyositis is an idiopathic inflammatory myopathy which can present with distinctive skin features. Despite the many treatment modalities for the treatment of dermatomyositis some patients remain refractory to treatment. We present a case of a 38‐year‐old man with recalcitrant dermatomyositis w...
Saved in:
Main Authors: | Shivang Chaudhary, Meghan Baumer, Laura Upton, Samantha Ong, Kristin Smith, Daniel West, Adam Kilian |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | ACR Open Rheumatology |
Online Access: | https://doi.org/10.1002/acr2.11792 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful treatment of recalcitrant cutaneous lupus erythematosus with anifrolumab in patients without systemic lupus erythematosus
by: Bishoy Abdelmalik, BS, et al.
Published: (2025-01-01) -
Efficacy of valaciclovir in preventing herpes zoster in patients receiving anifrolumab
by: Zahir Amoura, et al.
Published: (2025-01-01) -
Dual immunomodulator therapy with adalimumab and upadacitinib to treat recalcitrant hidradenitis suppurativa
by: Zahidul Islam, BA, et al.
Published: (2025-02-01) -
Recalcitrant Hailey-Hailey disease treated with isotretinoin: A family case series
by: Mahesh Mathur, MD, DCP, et al.
Published: (2025-02-01) -
Physiology‐based pharmacokinetic model with relative transcriptomics to evaluate tissue distribution and receptor occupancy of anifrolumab
by: Pradeep Sharma, et al.
Published: (2025-01-01)